Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01562431
Other study ID # P11SIG
Secondary ID 2008-4016
Status Completed
Phase N/A
First received December 20, 2011
Last updated January 23, 2014
Start date October 2011
Est. completion date June 2013

Study information

Verified date January 2014
Source The Netherlands Cancer Institute
Contact n/a
Is FDA regulated No
Health authority Netherlands: Medical Ethics Review Committee (METC)
Study type Interventional

Clinical Trial Summary

Background

An important part of individuals undergoing genetic counseling and/or testing for cancer experience psychosocial problems and worries during or after this process. Approximately 20% of these individuals experience serious problems, such as fear for cancer in themselves or their relatives, family communication problems, unresolved grief, problems in coping with the DNA-test-results, difficulties in choices with regard to DNA-testing, preventive surgeries, and concerns about insurance or work. Research shows that these problems are frequently undetected by the counselors. Within the limited available time of a counseling session, a lot of information should be given to the counselee. This information is mostly biomedical and provider driven. Therefore psychosocial issues can be underexposed. The use of a brief questionnaire, completed by the counselee prior to the counseling session, can serve as a tool for the counselor to screen and address the relevant psychosocial issues in a systematic manner. Therefore, in 2009-2010 the investigators have developed and validated the 'Signal-checklist' to identify relevant psychosocial problems frequently encountered in the cancer-genetics setting, and need for extra psychosocial services. This 'Signal-checklist' can serve as a tool in screening systematically for psychosocial issues, addressing these issues and directing appropriate referrals to extra psychosocial services. The Signal-Trial will be performed to evaluate the use and effectiveness of the checklist.

Aim

The aim of the trial is to evaluate the implementation of a short, self-developed cancer-genetics checklist; the 'Signal-checklist', as an aid in 1) facilitating communication on psychosocial issues during the genetic counseling session, 2) increasing counselors awareness of psychosocial problems of the counselee, and 3) improving the management of these psychosocial problems during and after the process of genetic counselling.

Method

This study is a collaboration between the family cancer clinics of the NKI-AVL and the UMCU. Individuals requesting genetic counseling for the high incidence of cancer in their family are invited to participate in the trial. Participants will be asked to complete the 'Signal checklist' prior to their counseling visit. Participants (N=264) will be randomly assigned to one of the two study arms. The intervention group will receive feed-back on the 'Signal-checklist', whereas the control group will not receive feed-back. Three weeks after the DNA-test disclosure session, participants will be asked to complete again the 'Signal-checklist' followed by a telephone call by their counselor. Again, the results of the 'Signal-checklist' will be available to the counselor for participants in the intervention group, but not for the control group. Both the genetic counseling session and telephone call will be audio taped. Furthermore, all participants will be asked to complete three questionnaires on the Internet (or by mail, if preferred); 1) before randomization (3 weeks prior to the counseling session), 2) three weeks after the counseling session, and 3) four months after the potential DNA-test result disclosure. These questionnaires include items on communication during genetic counseling, the need for professional psychosocial support, cancer worries, satisfaction with received care, and experiences with the use of the 'Signal-checklist'. The audio-tapes and completed questionnaires will be used to measure psychosocial problems of the counselees, the awareness of the counselors of these problems, and the management of these problems. Secondary analysis will be conducted to assess the need for extra psychosocial services, satisfaction with genetic counseling, feasibility of implementing the 'Signal-checklist' and decreasing psychosocial problems over time.


Recruitment information / eligibility

Status Completed
Enrollment 246
Est. completion date June 2013
Est. primary completion date January 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- 18 years of age or older

- Sufficient command of the Dutch language to be able to complete questionnaires

- Attendees of a second visit at the family cancer clinic because of increased risk of developing cancer due to a hereditary predisposition

Exclusion Criteria:

- Those who do not fulfill the inclusion criteria

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label


Related Conditions & MeSH terms


Intervention

Other:
Feed-back
Counselors will receive the results of the completed Signal-checklist completed by participants in the intervention group

Locations

Country Name City State
Netherlands Netherlands Cancer Institute Amsterdam Noord-Holland

Sponsors (2)

Lead Sponsor Collaborator
The Netherlands Cancer Institute UMC Utrecht

Country where clinical trial is conducted

Netherlands, 

Outcome

Type Measure Description Time frame Safety issue
Primary Communication on psychosocial issues at the counseling session The counseling session at the clinic will be audio taped, and content analyzed to evaluate counselor- counselee communication. A study-specific checklist will be used to rate whether psychosocial problems are discussed during the counseling session. 3 weeks after randomization No
Primary Counselors awareness of psychosocial problems of the counselee at the counseling session After each consult with a counselee, the counselor will have to complete a short form regarding their awareness of psychosocial problems of the counselee. The level of agreement between the counselor and the counselee will be assessed 3 weeks after randomization No
Primary Management of these psychosocial problems of the counselee during the counseling session Management of the psychosocial problems will be measured using the audio-taped sessions. The study-specific checklist will be used to rate whether problems are being counseled during the session and/or counselees are being referred to extra psychosocial services. 3 weeks after randomization No
Primary Communication on psychosocial issues at telephone follow-up The telephone follow-up will be audio taped, and content analyzed to evaluate counselor- counselee communication. A study-specific checklist will be used to rate whether psychosocial problems are discussed during the counseling session. up to 4 months after randomization No
Primary Counselors awareness of psychosocial problems of the counselee at follow-up After each consult with a counselee, the counselor will have to complete a short form regarding their awareness of psychosocial problems of the counselee. The level of agreement between the counselor and the counselee will be assessed Up to 4 months after randomization) No
Primary Management of these psychosocial problems of the counselee at follow-up Management of the psychosocial problems will be measured using the audio-taped sessions. The study-specific checklist will be used to rate whether problems are being counseled during the session and/or counselees are being referred to extra psychosocial services. Up to 4 months after randomization No
Secondary Initiation of discussed problems Counseling session (3 weeks after randomization) and telephone follow-up (up to 4 months after randomization) No
Secondary Time spent on psychosocial problems Counseling session (3 weeks after randomization) and telephone follow-up (up to 4 months after randomization) No
Secondary Counselee and counselor's level of satisfaction 4 weeks after counseling session (7 weeks after randomization) and 4 months after telephone follow-up (up to 8 months after randomization) No
Secondary Levels of counselee cancer worries Before randomization (Baseline, 1 week before randomization), 4 weeks after counseling session (7 weeks after randomization) and 4 months after telephone follow-up (up to 8 months after randomization) No
Secondary Number of psychosocial problems Counseling session (3 weeks after randomization) and telephone follow-up (up to 4 months after randomization) and 4 months after telephone follow-up (up to 8 months after randomization) No
Secondary Counselee and counselor evaluation of the intervention/ feasibility of the implementation of the intervention 4 weeks after counseling session (7 weeks after randomization) and 4 months after telephone follow-up (up to 8 months after randomization) No
See also
  Status Clinical Trial Phase
Completed NCT01866865 - Adaptation to Living With a BRCA1/2 Mutation
Completed NCT00339508 - Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics
Terminated NCT01374685 - Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans